HomeCompany overviewLeadership teamStrategy Advisory BoardPartners & InstitutionsTherapeutic AreasTherapeutic ApproachInnovative Lipid VectorsPipelineGAO-3-02 / GAO-11-02NewsContact

Strategic Advisory Board

Drug development is a highly challenging process. This is why GAOMA brought together advisors with complementary expertise. Our Strategic Advisory Board is currently composed of both international key opinion leaders in epilepsy and skilled executives, well established in the fields of business, management and entrepreneurship.